Boston Scientific said on Thursday it will buy medtech firm Penumbra in a deal valued at about $14.5 billion to expand its ...

Heart failure symptoms have been reversed in patients with a new pacemaker that changes how the heart is fuelled.

The French clinical stage company focused on cardiac innovation received the funds from a Series C funding round and the EC’s ...

Atrial fibrillation is one of the most common kinds of arrhythmia, causing the heart not to contract properly in order to ...

Supraglottic airway (SGA) devices used for out-of-hospital cardiac arrest (OHCA) were more successful at first attempt, but ...

Future Cardia, a medical device company, announced an expanded collaboration with remote cardiac monitoring company, Artella Solutions. Future Cardia is developing an implantable cardiac monitoring ...

Live Science spoke with Dr. Joe Alexander of NTT Research about "digital twins" and the development of an autonomous device for acute cardiac care.

Heart failure affects 6.5 million people in the U.S., with an additional 550,000 newly diagnosed each year. Heart failure hospitalizations are a leading cause of admissions for those 65 and older, ...

CINCINNATI, Ohio — Children and adolescents with pacemakers and implantable cardiac defibrillators (ICDs)--and their parents--suffer from a poorer quality of life than both healthy children and ...

A new survey finds nearly two‑thirds of Americans use smartwatches or other devices to track heart health, but only 1 in 4 ...

Heart disease, also called cardiovascular disease, can have serious consequences. It's the leading cause of death for adults in the U.S. Medical devices approved by the U.S. Food and Drug ...

The clinic will be able to accommodate 1,500 patients over a long period and 50 patients with a left ventricular assist ...